Revelation Biosciences, Inc. (REVB) Insider Ownership

Based on data from the past 90 days ending February 19, 2026, Revelation Biosciences's three largest insider shareholders are Chief Executive Officer James Rolke (224.85K shares), Chief Financial Officer Chester Stanley Iii Zygmont (105.35K shares), Director Jess Roper (12.83K shares).

• Revelation Biosciences's (REVB) total shares are held approximately -2662.22% by institutional investors, -8.26% by company insiders, and 2770.47% by other and public investors.
• Current insider holdings at Revelation Biosciences account for -8.26% of total shares outstanding as of February 19, 2026, totaling roughly 3.82K shares from the company's -46.22K share base.
• Over the past 90 days ending February 19, 2026, insider ownership at Revelation Biosciences increased by 52974.55%, with aggregate insider holdings growing from 7 to 3.82K shares.
• During the 90-day window concluding February 19, 2026, Chief Executive Officer James Rolke executed the largest insider acquisition at Revelation Biosciences, purchasing 532.83K shares.
• Chief Financial Officer Chester Stanley Iii Zygmont was the largest seller at Revelation Biosciences in the past 90 days, offloading 13.10K shares.